201 related articles for article (PubMed ID: 17970894)
1. The use of i.v. IG therapy in dermatology.
Fernandez AP; Kerdel FA
Dermatol Ther; 2007; 20(4):288-305. PubMed ID: 17970894
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin: use in dermatology.
Mydlarski PR; Mittmann N; Shear NH
Skin Therapy Lett; 2004 May; 9(5):1-6. PubMed ID: 15146260
[TBL] [Abstract][Full Text] [Related]
3. [Intravenous immunoglobulins in dermatology].
Nydegger U; Hunziker T
Ann Dermatol Venereol; 2002; 129(8-9):1078-81. PubMed ID: 12442118
[No Abstract] [Full Text] [Related]
4. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin: properties, mode of action and practical use in dermatology.
Prins C; Gelfand EW; French LE
Acta Derm Venereol; 2007; 87(3):206-18. PubMed ID: 17533485
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
Rütter A; Luger TA
J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
[TBL] [Abstract][Full Text] [Related]
7. [Toxic epidermal necrolysis. Therapy in ICU with intravenous immunoglobulins in a case].
Andresen M; Boghero Y; Molgó M; Dougnao A; Díaz O
Rev Med Chil; 2000 Dec; 128(12):1343-8. PubMed ID: 11227243
[TBL] [Abstract][Full Text] [Related]
8. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
Dalakas MC
Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
[TBL] [Abstract][Full Text] [Related]
9. Off-label uses of biologics in dermatology: interferon and intravenous immunoglobulin (part 1 of 2).
Smith DI; Swamy PM; Heffernan MP
J Am Acad Dermatol; 2007 Jan; 56(1):e1-54. PubMed ID: 17190617
[TBL] [Abstract][Full Text] [Related]
10. Novel mechanism for therapeutic action of IVIg in autoimmune blistering dermatoses.
Michael D; Grando SA
Curr Dir Autoimmun; 2008; 10():333-43. PubMed ID: 18460894
[TBL] [Abstract][Full Text] [Related]
11. Use of high-dose immunoglobulins in dermatology.
Enk A; Fierlbeck G; French L; Hertl M; Messer G; Meurer M; Steinbrink K; Stingl G; Volc-Platzer B; Zillikens D
J Dtsch Dermatol Ges; 2009 Sep; 7(9):806-812. PubMed ID: 19624804
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin treatment: Where do dermatologists stand?
Emre S
Dermatol Ther; 2019 May; 32(3):e12854. PubMed ID: 30756448
[TBL] [Abstract][Full Text] [Related]
13. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
[TBL] [Abstract][Full Text] [Related]
14. The use of intravenous immunoglobulin for treatment of dermatological conditions in Australia: A review.
Smith SD; Dennington PM; Cooper A
Australas J Dermatol; 2010 Nov; 51(4):227-37. PubMed ID: 21198517
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
16. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
Simeone F; Rubio ER
J La State Med Soc; 2003; 155(5):266-9. PubMed ID: 14748489
[TBL] [Abstract][Full Text] [Related]
17. IVIG for the treatment of toxic epidermal necrolysis.
Mittmann N; Chan BC; Knowles S; Shear NH
Skin Therapy Lett; 2007 Feb; 12(1):7-9. PubMed ID: 17361314
[TBL] [Abstract][Full Text] [Related]
18. Intravenous IgG: biological modulating molecules.
Luzi G; Bongiorno F; Paparo Barbaro S; Bruno G
J Biol Regul Homeost Agents; 2009; 23(1):1-9. PubMed ID: 19321040
[TBL] [Abstract][Full Text] [Related]
19. Toxic epidermal necrolysis treated with intravenous immunoglobulin and granulocyte colony-stimulating factor.
Kalyoncu M; Cimsit G; Cakir M; Okten A
Indian Pediatr; 2004 Apr; 41(4):392-5. PubMed ID: 15123870
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin and autoimmune disease.
El-Shanawany T; Jolles S
Ann N Y Acad Sci; 2007 Sep; 1110():507-15. PubMed ID: 17911466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
